VTR:NYE-Ventas Inc (USD)

COMMON STOCK | REIT - Healthcare Facilities |

Last Closing

USD 63.6

Change

0.00 (0.00)%

Market Cap

USD 27.32B

Volume

3.19M

Analyst Target

USD 38.42
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Ventas, Inc. (NYSE: VTR) is a leading S&P 500 real estate investment trust enabling exceptional environments that benefit a large and growing aging population. With approximately 1,350 properties in North America and the United Kingdom, Ventas occupies an essential role in the longevity economy. The Company's growth is fueled by its approximately 800 senior housing communities, which provide valuable services to residents and enable them to thrive in supported environments. The Ventas portfolio also includes outpatient medical buildings, research centers and healthcare facilities. The Company aims to deliver outsized performance by leveraging its unmatched operational expertise, data-driven insights from its Ventas OITM platform, extensive relationships and strong financial position. Ventas's seasoned team of talented professionals shares a commitment to excellence, integrity and a common purpose of helping people live longer, healthier, happier lives.

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-11-17 )

Largest Industry Peers for REIT - Healthcare Facilities

Symbol Name Price(Change) Market Cap
WELL Welltower Inc

N/A

USD 84.14B
DOC Healthpeak Properties Inc

N/A

USD 15.92B
CTRE CareTrust REIT Inc.

N/A

USD 5.63B
AHR American Healthcare REIT, Inc.

N/A

USD 4.16B
NHI National Health Investors Inc

N/A

USD 3.69B
LTC LTC Properties Inc

N/A

USD 1.71B
UHT Universal Health Realty Income..

N/A

USD 0.56B
CHCT Community Healthcare Trust Inc

N/A

USD 0.53B
GMRE-PA Global Medical REIT Inc

N/A

USD 0.41B
GMRE Global Medical REIT Inc

N/A

N/A

ETFs Containing VTR

BYRE Principal Exchange-Traded.. 8.53 % 0.00 %

N/A

USD 0.01B
WNEW:LSE WisdomTree New Economy Re.. 5.92 % 0.00 %

N/A

N/A
WTRE:LSE WisdomTree New Economy Re.. 5.92 % 0.00 %

N/A

N/A
WNER:LSE WisdomTree New Economy Re.. 5.02 % 0.00 %

N/A

USD 0.78M
WTNR:LSE WisdomTree New Economy Re.. 5.02 % 0.00 %

N/A

USD 2.56M
WTRE WisdomTree New Economy Re.. 4.99 % 0.00 %

N/A

USD 0.02B
WTRE:XETRA WisdomTree New Economy Re.. 4.69 % 0.00 %

N/A

USD 2.55M
WTER:XETRA WisdomTree New Economy Re.. 4.69 % 0.00 %

N/A

USD 3.43M
JPRE JPMorgan Realty Income ET.. 4.56 % 0.00 %

N/A

USD 0.38B
DJRE:AU SPDR Dow Jones Global Rea.. 2.20 % 0.00 %

N/A

USD 0.43B
TRET:SW VanEck Global Real Estate.. 2.08 % 0.00 %

N/A

USD 0.32B
RENT:AU 2.03 % 0.00 %

N/A

N/A
GLRA:LSE SPDR® Dow Jones Global R.. 1.84 % 0.00 %

N/A

USD 0.04B
GBRE:SW SPDR® Dow Jones Global R.. 1.72 % 0.00 %

N/A

USD 0.27B
GLRA:SW SPDR® Dow Jones Global R.. 1.72 % 0.00 %

N/A

USD 0.04B
ENGUS:PA BNP Paribas Easy ECPI Glo.. 1.12 % 0.00 %

N/A

N/A
DRW 0.00 % 0.58 %

N/A

N/A
EWRE 0.00 % 0.40 %

N/A

N/A
REZ iShares Residential and M.. 0.00 % 0.48 %

N/A

USD 1.21B
OLD 0.00 % 0.50 %

N/A

N/A
WREI 0.00 % 0.32 %

N/A

N/A
ENG:PA BNP Paribas EASY ECPI Glo.. 0.00 % 0.00 %

N/A

USD 0.24B
TRET:F VanEck Vectors ETFs N.V. .. 0.00 % 0.00 %

N/A

USD 0.28B
XU61:F BNP Paribas Easy SICAV - .. 0.00 % 0.00 %

N/A

USD 0.24B
SPYJ:XETRA SPDR® Dow Jones Global R.. 0.00 % 0.00 %

N/A

USD 0.27B
TRET:XETRA VanEck Vectors ETFs N.V. .. 0.00 % 0.00 %

N/A

USD 0.28B
XU61:XETRA BNP Paribas EASY ECPI Glo.. 0.00 % 0.00 %

N/A

USD 0.27B
CGRE:CA CI Global REIT Private Po.. 0.00 % 0.00 %

N/A

CAD 0.06B
SPY2:XETRA SPDR® Dow Jones Global R.. 0.00 % 0.00 %

N/A

USD 0.27B
TREG:LSE VanEck Vectors ETFs N.V. .. 0.00 % 0.00 %

N/A

USD 0.31B
TRET:LSE VanEck Vectors ETFs N.V. .. 0.00 % 0.00 %

N/A

USD 0.31B
SPY2:F SSgA SPDR ETFs Europe I P.. 0.00 % 0.00 %

N/A

USD 0.27B

Market Performance

  Market Performance vs. Industry/Classification (REIT - Healthcare Facilities) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 27.61% 57% F 84% B
Dividend Return 2.71% 8% B- 46% F
Total Return 30.32% 57% F 85% B
Trailing 12 Months  
Capital Gain 42.79% 71% C- 87% B+
Dividend Return 4.04% 15% F 52% F
Total Return 46.83% 79% B- 87% B+
Trailing 5 Years  
Capital Gain 8.44% 77% C+ 50% F
Dividend Return 16.50% 23% F 53% F
Total Return 24.94% 62% D 47% F
Average Annual (5 Year Horizon)  
Capital Gain 8.63% 80% B- 62% D
Dividend Return 12.38% 80% B- 66% D+
Total Return 3.75% 20% F 73% C
Risk Return Profile  
Volatility (Standard Deviation) 31.60% 13% F 33% F
Risk Adjusted Return 39.19% 67% D+ 56% F
Market Capitalization 27.32B 90% A- 93% A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
High dividend returns

The stock has outperformed its sector peers on average annual dividend returns basis in the past 5 years (for a hold period of at least 12 months) and is in the top quartile. This can be a good buy, especially if it is outperforming on total return basis , for investors seeking high income yields.

High market capitalization

This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.

Positive cash flow

The company had positive total cash flow in the most recent four quarters.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

Superior Dividend Growth

This stock has shown top quartile dividend growth in the previous 5 years compared to its sector

What to not like:
Highly leveraged

The company is in the bottom half compared to its sector peers on debt to equity and is highly leveraged. However, do check the news and look at its sector and management statements. Sometimes this is high because the company is trying to grow aggressively.

Poor return on assets

The company management has delivered below median return on assets in the most recent 4 quarters compared to its peers.

Poor capital utilization

The company management has delivered below median return on invested capital in the most recent 4 quarters compared to its peers.

Overpriced on cashflow basis

The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Overpriced compared to book value

The stock is trading high compared to its peers median on a price to book value basis.

Overpriced compared to earnings

The stock is trading high compared to its peers on a price to earning basis and is above the sector median.

Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.

High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.

Overpriced on free cash flow basis

The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Low Earnings Growth

This stock has shown below median earnings growth in the previous 5 years compared to its sector

Low Revenue Growth

This stock has shown below median revenue growth in the previous 5 years compared to its sector